Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thanh H Dellinger

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Gynecologic Oncology|May 5, 2012
Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancerThanh H Dellinger, Kestutis Planutis, Danielle D Jandial, et al.
Cancer Research Communications|November 30, 2023
Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian CancerFerdynand J Kos, Paul Frankel, Mihaela Cristea, et al.
Plos One|January 18, 2013
Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancerChunmei Yang, Heehyoung Lee, Veronica Jove, et al.
Oncotarget|May 15, 2018
Identification of core aberrantly expressed microRNAs in serous ovarian carcinomaSteven F Chen, Zheng Liu, Shyambabu Chaurasiya, et al.
Annals of Surgical Oncology|June 1, 2017
Base Excess as a Predictor of Complications in Cytoreductive Surgery with Hyperthermic Intraperitoneal ChemotherapyOliver S Eng, Sinziana Dumitra, Michael O'Leary, et al.
JAMA Surgery|August 24, 2017
Association of Fluid Administration With Morbidity in Cytoreductive Surgery With Hyperthermic Intraperitoneal ChemotherapyOliver S Eng, Sinziana Dumitra, Michael O'Leary, et al.
Annals of Surgical Oncology|September 13, 2024
Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 TrialMuhammad Talha Waheed, Nora Ruel, Richard L Whelan, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 29, 2016
Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer modelsCai M Roberts, Sophia Allaf Shahin, Wei Wen, et al.
Journal of Surgical Oncology|June 8, 2018
A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancerOliver S Eng, Mustafa Raoof, Andrew M Blakely, et al.
Molecular Cancer|May 1, 2015
Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancerWei Wen, Jun Wu, Lucy Liu, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Gynecologic Oncology|May 5, 2012
Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancerThanh H Dellinger, Kestutis Planutis, Danielle D Jandial, et al.
Cancer Research Communications|November 30, 2023
Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian CancerFerdynand J Kos, Paul Frankel, Mihaela Cristea, et al.
Plos One|January 18, 2013
Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancerChunmei Yang, Heehyoung Lee, Veronica Jove, et al.
Oncotarget|May 15, 2018
Identification of core aberrantly expressed microRNAs in serous ovarian carcinomaSteven F Chen, Zheng Liu, Shyambabu Chaurasiya, et al.
Annals of Surgical Oncology|June 1, 2017
Base Excess as a Predictor of Complications in Cytoreductive Surgery with Hyperthermic Intraperitoneal ChemotherapyOliver S Eng, Sinziana Dumitra, Michael O'Leary, et al.
JAMA Surgery|August 24, 2017
Association of Fluid Administration With Morbidity in Cytoreductive Surgery With Hyperthermic Intraperitoneal ChemotherapyOliver S Eng, Sinziana Dumitra, Michael O'Leary, et al.
Annals of Surgical Oncology|September 13, 2024
Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 TrialMuhammad Talha Waheed, Nora Ruel, Richard L Whelan, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 29, 2016
Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer modelsCai M Roberts, Sophia Allaf Shahin, Wei Wen, et al.
Journal of Surgical Oncology|June 8, 2018
A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancerOliver S Eng, Mustafa Raoof, Andrew M Blakely, et al.
Molecular Cancer|May 1, 2015
Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancerWei Wen, Jun Wu, Lucy Liu, et al.
Pageof 5